Innospec Inc.
NASDAQ:IOSPChemicals - Specialty
+$0.08 today
- Market cap
- $1.94B
- Beta
- 0.91
- P/E (TTM)
- 18.0
- EPS (TTM)
- $4.61
- Dividend yield
- 2.15%
Volume 0.23M
Average 0.24M
IOSP Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Innospec Inc.NASDAQ: IOSP
Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026
Accounts receivables turns negative
Q2 FY2026 accounts receivables was -$70.2M, compared with $22.3M a year earlier. Trailing-twelve-month accounts receivables was -$91.2M.
Context
- Accounts receivables amounted to 1.2% of revenue in FY2025, up 1.0 pp from a year earlier.
- Accounts receivables increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts receivables holds near -$70.2M or moves back toward the trailing-twelve-month quarterly average of -$22.8M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 21.6M USD
- Year-over-year change
- +402.3%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21.6M | +402.3% |
| FY2024 | 2024-12-31 | 4.3M | +134.1% |
| FY2023 | 2023-12-31 | (12.6M) | +77.3% |
| FY2022 | 2022-12-31 | (55.5M) | -76.8% |
| FY2021 | 2021-12-31 | (31.4M) | — |
Accounts Receivables vs competitors
How IOSP compares with its peers on the latest reported figures
- IOSP's LTM Jun 2026 accounts receivables of $91.2M is the 3rd largest of the 10 companies compared; the peer median is $17.56M.
- Its year-over-year change of +328.2% is the 2nd highest of 8, against a peer median of -98.5%.
- Accounts receivables amounts to 5.0% of revenue for IOSP, versus a peer median of 1.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $234.6M | — | — | 4.5% | |
| LTM Jun 2026 | $125M | +635.3% | -13.1% | 1.4% | |
| LTM Jun 2026 | $91.2M | +328.2% | — | 5.0% | |
| LTM Aug 2026 | $78.97M | +316.5% | -48.2% | 2.2% | |
| LTM Sep 2026 | $53.27M | -696.2% | — | 2.6% | |
| LTM Sep 2026 | $17.56M | +161.8% | -27.2% | 1.5% | |
| LTM Jun 2026 | $10.65M | — | -47.4% | 0.4% | |
| LTM Mar 2026 | $5.44M | -129.7% | +57.9% | 4.9% | |
| LTM Jun 2026 | $1M | -98.5% | — | 0.0% | |
| LTM Jun 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding IOSP) | $17.56M | -98.5% | -27.2% | 1.5% | |
Competitors are the stored peer set for IOSP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 93.1M | 133M | 139.1M | 35.6M | 116.6M |
| Depreciation & Amortization | 42.7M | 40.1M | 39.3M | 43.5M | 43.6M |
| Deferred Income Tax | 6.4M | (5.5M) | 3.6M | (39.3M) | (10.2M) |
| Stock-Based Compensation | 4.4M | 6.7M | 8M | 8.5M | 8.1M |
| Change in Working Capital | (48.1M) | (90.1M) | 20.6M | (18.9M) | (48.4M) |
| Accounts Receivables | (31.4M) | (55.5M) | (12.6M) | 4.3M | 21.6M |
| Inventory | (62M) | (98.5M) | 83M | (11.8M) | (6.6M) |
| Accounts Payables | 90.2M | 54.2M | (26.9M) | (4.5M) | (32.8M) |
| Other Working Capital | (44.9M) | 9.7M | (22.9M) | (6.9M) | (30.6M) |
| Other Non-Cash Items | (5.3M) | (2.5M) | (3.3M) | 155.1M | 28.6M |
| Operating Cash Flow | 93.2M | 81.7M | 207.3M | 184.5M | 138.3M |
| Capital Expenditures | (39.1M) | (42.3M) | (62.1M) | (41.4M) | (50.3M) |
| Acquisitions (Net) | 3M | 2M | (34.7M) | (200K) | (700K) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (100K) | (1.8M) | 100K | 500K | (24.1M) |
| Investing Cash Flow | (36.2M) | (42.1M) | (111.8M) | (62M) | (75.1M) |
| Debt Repayment | (600K) | (100K) | (2.3M) | 0 | 0 |
| Common Stock Issued | 10.1M | 2.2M | 900K | 2.1M | 500K |
| Common Stock Repurchased | (800K) | (5.9M) | (1.1M) | (700K) | (23.9M) |
| Dividends Paid | (28.8M) | (31.7M) | (35.1M) | (38.8M) | (42.4M) |
| Other Financing Activities | 100K | 1.8M | (1.4M) | 2.1M | 1.9M |
| Financing Cash Flow | (20M) | (33.7M) | (39M) | (35.3M) | (63.9M) |
| Effect of Forex Changes | (500K) | (600K) | 100K | (1.7M) | 4M |
| Net Change in Cash | 36.5M | 5.3M | 56.6M | 85.5M | 3.3M |
| Free Cash Flow | 54.1M | 39.4M | 145.2M | 143.1M | 88M |
Innospec Inc.
NASDAQ:IOSP
Intrinsic Alpha fair value
Locked
Current Price
$78.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.